Skip to main content

Year: 2022

Sun Country Airlines Announces Appointment of Jennifer Vogel to Board of Directors

MINNEAPOLIS, Oct. 14, 2022 (GLOBE NEWSWIRE) — Sun Country Airlines (NASDAQ: SNCY) has appointed Jennifer L. Vogel, former senior vice president, general counsel, secretary and chief compliance officer of Continental Airlines, Inc., to its board of directors effective October 14, 2022. “I am honored to introduce Jennifer as our newest board member,” says board chair David Siegel. “Her decades of leadership in the aviation industry, along with her corporate board and governance experience, will provide valuable insights for our own organization.” Vogel brings over 30 years of leadership experience as both a corporate executive and serving on public boards. At Continental, she played key roles in rebuilding the airline’s business, helping it to achieve substantial global expansion, and significantly restructure and rebuild after 9/11....

Continue reading

Islandsbanki hf.: Íslandsbanki enters a market making agreement for covered bonds

Íslandsbanki hf. has signed market-making agreements with Arion bank hf., Kvika hf., and Landsbankinn regarding covered bonds issued by Íslandsbanki on NASDAQ Iceland. The purpose of the agreements is to stimulate trading in the bonds in order to generate normal market prices and to foster effective and transparent price formation. The market makers will place bid and ask orders for the bonds every day. Market makers are not obliged to submit bids and asks for new bond series until the series has reached ISK 3 billion and the minimum bid /ask size shall be ISK 20 million until the series has reached ISK 5 billion, when the minimum shall increase to ISK 60 million until the series has reached ISK 10 billion and then the minimum shall be ISK 80 million. The series ISB CBI 24, ISB CBI 26 and ISB CBI 30 are not subject to the aforementioned...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for November 15, 2022

CALGARY, Alberta, Oct. 14, 2022 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to October 2022 of $0.05 per common share is to be paid on November 15, 2022, for shareholders of record on October 31, 2022. The ex-dividend date for the October dividend is October 28, 2022. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the CEO and includes estimates of monthly capital expenditures and production. For further information...

Continue reading

Canoe EIT Income Fund Announces 2022 Voluntary Cash Redemption

CALGARY, Alberta, Oct. 14, 2022 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (“Canoe” or the “Fund”)(TSX – EIT.UN) today announced the 2022 voluntary cash redemption. Voluntary Annual Cash Redemption The redemption date for the Fund’s annual voluntary cash redemption will be December 9, 2022. Unitholders are entitled to redeem units of the Fund at a price equal to 95% of the Average Net Asset Value (NAV) of the three trading days preceding the December 9, 2022 redemption date, less direct costs. Direct costs are expected to be less than 1%. If all redemption requests exceed 10% of the aggregate outstanding units of the Fund on November 18, 2022, the final day to submit units for redemption, the Fund will process redemptions to this maximum on a pro-rata basis based on the total number of units tendered. Payment for units that...

Continue reading

VR COMPLETES FINANCINGS, FOR AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $2.3 MILLION.

VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR; FSE: 5VR; OTCQB: VRRCF) (the “Company” or “VR”) is pleased to announce, further to its news releases dated September 15 and 26, 2022, the second and final closing of the previously announced non-brokered Flow Through private placement (the “FT Financing”). In connection with the second tranche closing of the FT Financing, the Company issued today an additional 1,670,000 FT Units (as defined below). In addition to the FT Financing, the Company recently completed its second and final closing of its non-brokered Hard dollar private placement (the “Hard dollar Financing”, and collectively, the “Financings”) (see NR22-11, NR22-12 and NR22-14 dated August 19, August 30 and September 26, 2022, respectively). The closing of the Financings is in...

Continue reading

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion of 12-week follow up anticipated by year end with data shortly thereafter SSRI drug interaction study initiated MHRA approval for new SPL026 trial LONDON, Oct. 14, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, has today published its financial results for the three and six months ended August 31, 2022. A full copy of the financial results can be found under the Company’s profile on SEDAR at www.sedar.com. Unless otherwise indicated, all currency references are in Canadian dollars. Financial Highlights (including...

Continue reading

SAFEGUARD SCIENTIFICS ANNOUNCES TRANSFER TO NASDAQ

SFE ticker symbol remains the same RADNOR, Pa., Oct. 14, 2022 (GLOBE NEWSWIRE) — Safeguard Scientifics, Inc. (NYSE: SFE) today announced that it will transfer its common stock exchange listing from the New York Stock Exchange to the NASDAQ Capital Market (“NASDAQ”). Safeguard expects to commence trading as a NASDAQ-listed company upon market open on October 26, 2022. Safeguard’s common stock will continue to trade under the ticker symbol SFE. “This transfer to NASDAQ will provide further cost savings for our shareholders and greater corporate flexibility as we pursue portfolio exits and value maximization strategies going forward,” commented Eric Salzman, Chief Executive Officer. About Safeguard Scientifics Historically, Safeguard Scientifics has provided capital and relevant expertise to fuel the growth of technology-driven businesses....

Continue reading

Closing of $400 million notes of CNH Industrial Capital LLC

London, October 14, 2022 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) today announced that its wholly owned subsidiary, CNH Industrial Capital LLC, has completed its previously announced offering of $400 million in aggregate principal amount of 5.450% notes due 2025, with an issue price of 99.349%. The net proceeds of this offering were approximately $395 million after payment of offering and other related expenses. CNH Industrial Capital LLC intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, including, among other things, the purchase of receivables or other assets in the ordinary course of business. The net proceeds may also be applied to repay CNH Industrial Capital LLC’s indebtedness as it becomes due. The notes, which are senior unsecured obligations...

Continue reading

Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination

TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate amount of $1,035,000 (representing $0.10 per public share) (the “Extension Payment”) into the Company’s trust account for its public stockholders. This deposit enables the Company to extend the date by which the Company has to complete its initial business combination from October 13, 2022 to January 13, 2023 (the “Extension”). The Extension is the first of two three-month extensions permitted under the Company’s governing documents. The Extension provides the Company with additional time to complete its initial business combination with Apollomics Inc. (“Apollomics”), previously announced...

Continue reading

Syneos Health Appoints William E. Klitgaard Independent Director

MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E. Klitgaard to its Board of Directors. Mr. Klitgaard was previously a member of the Syneos Board from 2017 until May 2022, having resigned due to a personal matter. The Company also announced today that Todd M. Abbrecht is stepping down from its Board of Directors. “We are excited to welcome Bill back to the Syneos Health Board,” said John Dineen, Chair of the Syneos Health Board of Directors. “Bill’s deep financial expertise combined with his knowledge of our company are a welcome addition to an already strong Board, enhancing its composition. This appointment will support continued successful oversight of our strategy as we speed our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.